Inventor · disambiguated record
Emanuela Lovati
Also filed as: LOVATI EMANUELA
8 granted patents·4 pending applications·28 citations·filing 2012–2022
83Inventor score
Top patents by PatentIndex Score
12 records- 0194US8426450B1Substituted 4-phenyl pyridines having anti-emetic effectFADINI LUCA·Filed 2012·Granted Apr 23, 2013·22 cites·3 claims
- 0289US10208073B2Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2018·Granted Feb 19, 2019·2 cites·13 claims
- 0385US9403772B24-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2012·Granted Aug 2, 2016·4 cites·14 claims
- 0479US12071421B2Process for the synthesis of substituted chloromethyl dialkylphosphatesHELSINN HEALTHCARE SA·Filed 2022·Granted Aug 27, 2024·0 cites·3 claims
- 0575US11312698B2Fosnetupitant chloride hydrochloride having improved stabilityHELSINN HEALTHCARE SA·Filed 2020·Granted Apr 26, 2022·0 cites·12 claims
- 0671US10717721B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2018·Granted Jul 21, 2020·0 cites·2 claims
- 0767US9908907B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 0864US8895586B2Methods of treating emesisFADINI LUCA·Filed 2013·Granted Nov 25, 2014·0 cites·21 claims
- 0959US2025205216A2Piperidine Urea Derivatives for Use as Inotropic AgentsLUND LARS·Filed 2022·Application pending·0 cites
- 1056US2024000791A1Methods of Using 4-Amino-N-[4-(Methoxymethyl)Phenyl]-7-(1-Methylcyclopropyl)-6-(3-Morpholinoprop-1-YN-1-YL)-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carboxamide for the Treatment of TumorsHELSINN HEALTHCARE SA·Filed 2021·Application pending·0 cites
- 1153US2018177849A1Therapeutic Uses of ElsiglutideHELSINN HEALTHCARE SA·Filed 2017·Application pending·0 cites
- 1241US2017087216A1Therapeutic Uses of ElsiglutideHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emanuela Lovati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →